IndraLab

Statements


XSN inhibits KCNH2. 2 / 2
| 2

reach
"In this study, we revealed that XSN blocks hNaV1.5 sodium channel and hERG potassium channel, which has placed XSN as a class I and III antiarrhythmic medicine as the widely used antiarrhythmic drug amiodarone."

reach
"As we reported previously that XSN blocked human hERG channels in a dose dependent manner with an IC 50 of 0.34 mg/ml; the data were applied to computational simulation of human AP."